The efficacy and safety of predischarge initiation of angiotensin receptor/neprilysin inhibitor in patients with severe left ventricular dysfunction hospitalized for acute decompensated heart failure: Single-center experience

Kardiol Pol. 2023;81(9):913-915. doi: 10.33963/KP.a2023.0132. Epub 2023 Jun 18.

Authors

Marcin Książczyk¹, Małgorzata Lelonek²

Affiliations

¹ Department of Noninvasive Cardiology, Medical University of Lodz, Łódź, Poland. marcin_ksiazczyk@interia.pl.
² Department of Noninvasive Cardiology, Medical University of Lodz, Łódź, Poland.

PMID: 37331020
DOI: 10.33963/KP.a2023.0132

No abstract available

MeSH terms

Angiotensin Receptor Antagonists / adverse effects
Antihypertensive Agents / pharmacology
Drug Combinations
Heart Failure* / drug therapy
Humans
Neprilysin / antagonists & inhibitors
Receptors, Angiotensin
Stroke Volume
Tetrazoles / pharmacology
Ventricular Dysfunction, Left* / drug therapy

Substances

Angiotensin Receptor Antagonists
Antihypertensive Agents
Drug Combinations
Neprilysin
Receptors, Angiotensin
Tetrazoles